Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)

• Benjamin S. Collyer ,

  Roles Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing

  * E-mail: b.collyer@imperial.ac.uk

  Affiliation Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary’s Campus, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0002-6773-408X

  ⨯
• Michael A. Irvine,

  Roles Methodology, Software, Writing – review & editing

  Affiliation Institute of Applied Mathematics, University of British Columbia, Vancouver, Canada

  ⨯
• T. Deidre Hollingsworth,

  Roles Methodology, Software

  Affiliation Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Mark Bradley,

  Roles Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing

  Affiliation Global Health Program, GlaxoSmithKline (GSK), Brentford, United Kingdom

  http://orcid.org/0000-0001-7377-3213

  ⨯
• Roy M. Anderson

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary’s Campus, Imperial College London, London, United Kingdom

  ⨯